This inventor holds 1 USPTO granted patent and 1 published patent application and 2 EPO patents. Top assignee: Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Marshall Devor: Innovator in Epilepsy Treatment
Introduction
Marshall Devor is a notable inventor based in Jerusalem, Israel. He has made significant contributions to the field of medicine, particularly in the treatment of epilepsy. His innovative work has led to the development of valuable pharmaceutical compounds.
Latest Patents
Marshall Devor holds a patent for "Amide derivatives of valproic acid and uses thereof." This patent focuses on the use of amide derivatives of valproic acid in the treatment of epilepsy. His research has the potential to improve therapeutic options for patients suffering from this condition. He has 1 patent to his name.
Career Highlights
Devor is associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. His work at this esteemed institution has allowed him to explore and develop innovative solutions in the medical field. His dedication to research and development has positioned him as a key figure in his area of expertise.
Collaborations
Throughout his career, Marshall Devor has collaborated with esteemed colleagues, including Meir Bialer and Boris Yagen. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
Marshall Devor's contributions to the treatment of epilepsy through his innovative patent demonstrate his commitment to advancing medical science. His work continues to inspire future research and development in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile